Wolters Kluwer Health Announces Strategic Agreement with Epic


The Wolters Kluwer Health products that will be available to Epic customers include Medi-Span Knowledge Bases, which include databases for screening and reviewing drug-drug interactions, drug-lab conflicts, drug indications and adverse drug effects. Medi-Span Knowledge Bases will be integrated into the information systems used by clinicians in inpatient, ambulatory and operating room settings, along with pharmacy dispensing applications. 
 
In addition, WKHealth's clinical decision support products will be available, including Clin-eguide and SkolarMD.  Clin-eguide order sets feature standardized orders for a wide array of high-volume inpatient and outpatient clinical conditions, supported by links to the medical evidence. SkolarMD is an Internet-based medical knowledge solution that helps healthcare professionals find answers to clinical questions by rapidly searching multiple sources of highly regarded medical information, such as textbooks, journals, evidence-based guides and pharmaceutical references.
 
"In a time when there is an overwhelming amount of clinical knowledge available to healthcare professionals, we are pleased that by working with Epic we can give clinicians high-quality, organized and relevant information through the platform that they already know and trust,"  said Nancy Greengold, MD, vice president of clinical decision support for Wolters Kluwer Health. "By expanding our partnership, we are furthering our mission to bring evidence-based clinical knowledge and comprehensive healthcare information to the point of patient care."
 
About Wolters Kluwer Health
Wolters Kluwer Health (Philadelphia) is a leading provider of information for professionals and students in medicine, nursing, allied health, pharmacy and the pharmaceutical industry. Major brands include traditional publishers of medical and drug reference tools and textbooks, such as Lippincott Williams & Wilkins and Facts & Comparisons; electronic information providers, such as Ovid Technologies, Medi-Span and SKOLAR; and pharmaceutical information provider Adis International. Leveraging its broad array of industry-leading intellectual property, Wolters Kluwer Health is creating integrated drug and disease databases and point-of-care information tools for healthcare professionals. These tools aid disease management, medication error reduction, workflow improvement and more effective patient management. Wolters Kluwer Health has annual revenues (2003) of €663 million and is a division of Wolters Kluwer.
 
Wolters Kluwer is a leading multinational publisher and information services company. The company's core markets are spread across the health, tax, accounting, corporate, financial services, legal and regulatory, and education sectors. Wolters Kluwer has annual revenues (2003) of €3.4 billion, employs approximately 18,750 people worldwide and maintains operations across Europe, North America and Asia Pacific. Wolters Kluwer is headquartered in Amsterdam, the Netherlands. Its depositary receipts of shares are quoted on the Euronext Amsterdam (WKL) and are included in the AEX and Euronext 100 indices.
 
Media
Connie Hofmann
Director, Communications
Wolters Kluwer Health
t + 1 215 521 8511
chofmann@wkhealth.com
 
Caroline Wouters
Vice President, Corporate Communications
Wolters Kluwer nv
t + 31 (0)20 6070 459
press@wolterskluwer.com
 
Investors/Analysts
Oya Yavuz
Vice President, Investor Relations
Wolters Kluwer nv
t + 31 (0)20 6070 407
ir@wolterskluwer.com
 

Attachments

PDF version of press release
GlobeNewswire

Recommended Reading